文献速递心血管CT

基于人工智能的定量冠状动脉CT血管成像与人阅片者视觉评估的预后价值比较:CONFIRM2登记研究结果

Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry.
PubMed 文献 · JACC Cardiovasc Imaging · 2025-12-01

CONFIRM2为多中心国际观察性队列研究,纳入1916例接受临床指征冠状动脉CTA且有全部风险评分的患者,随访3年发生87例(4.5%)主要不良心脏事件和27例(1.4%)死亡/心肌梗死。AI-QCT在CAD-RADS、CACS、改良Duke指数及CAD-RADS+CACS模型基础上均显著改善MACE风险分层(AUC 0.81 vs 0.79等,NRI 0.47~0.61),并改善死亡/心肌梗死预测。

要点

  • AI-QCT较CAD-RADS、CACS、改良Duke指数及CAD-RADS+CACS模型均显著改善MACE风险分层,AUC提升至0.81。
  • 排除195例重度狭窄(≥70%)患者后,多变量模型中仅AI-QCT与MACE及死亡/心肌梗死显著相关。
  • AI-QCT在调整风险因素加权临床似然后仍改善判别能力,并改善死亡/心肌梗死预测。

核心结论

  • AI-QCT较CAD-RADS 2.0、CACS及改良Duke指数对MACE及次要终点死亡或非致死性心肌梗死提供增量预后信息。

研究设计与样本

  • CONFIRM2为多中心、国际、观察性队列研究,纳入1916例有全部风险评分、接受临床指征冠状动脉CTA并随访MACE的患者,排除无症状及有心脏病史者。

关键影像表现/征象

  • AI-QCT在全冠状动脉树量化冠状动脉疾病的存在、范围和成分,产生24个患者、血管和斑块层面变量。
  • 基于既往分析,非钙化斑块负荷和直径狭窄被确定为最强预测因子,并合并为统计建模的「AI-QCT」。
  • CAD-RADS和CACS分类越高,风险呈逐步增加。

诊断标准与关键数值

  • AI-QCT联合CAD-RADS预测MACE:AUC 0.81 vs 0.79(P < 0.001),NRI 0.47(P < 0.001)。
  • AI-QCT联合CACS预测MACE:AUC 0.79 vs 0.70(P < 0.001),NRI 0.61(P < 0.001)。
  • AI-QCT联合改良Duke指数预测MACE:AUC 0.81 vs 0.76(P < 0.001),NRI 0.52(P < 0.001)。
  • AI-QCT联合CAD-RADS+CACS模型预测MACE:AUC 0.81 vs 0.79(P = 0.004),NRI 0.54(P < 0.001)。
  • 排除195例重度狭窄(≥70%)患者后,AI-QCT联合CAD-RADS预测MACE:AUC 0.77 vs 0.72(P < 0.001),NRI 0.54(P < 0.001);预测死亡/心肌梗死:AUC 0.81 vs 0.73(P = 0.011),NRI 0.69(P = 0.001)。

临床应用与阅片要点

  • 原文结论为AI-QCT较CAD-RADS 2.0、CACS及改良Duke指数对MACE及死亡或非致死性心肌梗死提供增量预后信息。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: The severity and extent of whole heart coronary plaque volume and stenosis can be reliably measured by artificial intelligence-guided quantitative coronary computed tomography angiography (AI-QCT). Limited data are available on the potential incremental prognostic value compared with currently recommended qualitative coronary computed tomography angiography (CTA) reads and the coronary artery calcium score (CACS).

OBJECTIVES: The aim of this study was to evaluate the prognostic value of AI-QCT compared with human coronary CTA reads, including the CAD-RADS (Coronary Artery Disease-Reporting and Data System), CACS, and the modified Duke Index.

METHODS: CONFIRM2 (Quantitative COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) is a multicenter, international, observational cohort study of patients undergoing clinically indicated coronary CTA with follow-up for major adverse cardiac events (MACE). Asymptomatic patients and those with cardiac history were excluded. Coronary artery disease presence, extent, and composition were quantified by AI-QCT across the coronary tree, yielding 24 patient-, vessel-, and plaque-level variables. On the basis of prior analyses, noncalcified plaque burden and diameter stenosis were identified as the strongest predictors and combined for statistical modeling as "AI-QCT." Comparator computed tomography scores included CAD-RADS, CACS, and the modified Duke Index, whereas clinical predictors were summarized in the risk factor-weighted clinical likelihood score. Area under the curve (AUC) and continuous net reclassification index (NRI) were calculated to assess the incremental value. The primary endpoint was MACE (death, myocardial infarction [MI], stroke, heart failure, late revascularization, or hospital stay for unstable angina), and the secondary endpoint was death or MI.

RESULTS: In 1,916 patients with all risk scores available, 87 (4.5%) MACE and 27 (1.4%) death/MI events occurred during 3 years of follow-up. There was a stepwise risk increase with higher coronary artery disease classifications with CAD-RADS and CACS. The addition of AI-QCT significantly improved risk stratification for MACE compared with CAD-RADS (AUC: 0.81 vs 0.79; P < 0.001 and NRI: 0.47; P < 0.001), CACS (AUC: 0.79 vs 0.70; P < 0.001 and NRI 0.61; P < 0.001), the modified Duke Index (AUC: 0.81 vs 0.76; P < 0.001 and NRI: 0.52; P < 0.001), and CAD-RADS + CACS model (AUC: 0.81 vs 0.79; P = 0.004 and NRI: 0.54; P < 0.001). AI-QCT also improved discrimination when results were adjusted for the risk factor-weighted clinical likelihood and for the prediction of death/MI. Excluding 195 patients with severe stenosis (≥70%), in a multivariable model of CAD-RADS and AI-QCT, only AI-QCT was significantly associated with MACE and death/MI, and AI-QCT significantly improved risk stratification compared with CAD-RADS for MACE (AUC: 0.77 vs 0.72; P < 0.001 and NRI: 0.54; P < 0.001) and death/MI (AUC: 0.81 vs 0.73; P = 0.011 and NRI: 0.69; P = 0.001).

CONCLUSIONS: AI-QCT provided incremental prognostic information compared with CAD-RADS 2.0, CACS, and the modified Duke Index for the prediction of MACE as well as the secondary endpoint of death or nonfatal MI.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. van Rosendael A, Nakanishi R, Bax JJ, et al. Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry. JACC Cardiovasc Imaging. 2025. PMID: 41324522. doi:10.1016/j.jcmg.2025.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。